Medtronic Receives FDA Approval for Sprint Fidelis Defibrillation Leads

Strategic Insights -

Medtronic, Inc., a leading medical technology company, has announced the U.S. Food and Drug Administration approval of the Sprint Fidelis family of defibrillation leads for patients at risk of sudden cardiac arrest. This breakthrough development allows for the implantation of smaller and more efficient defibrillation leads, which are crucial for patients requiring an implantable cardioverter-defibrillator (ICD) or pacemaker. The Sprint Fidelis leads measure 6.6 French in size, making them the world's smallest right ventricular defibrillation leads, and are compatible with 7 French introducers. This innovation is set to significantly improve the implantation process and patient outcomes.

Key Takeaways:

  • The Sprint Fidelis family of defibrillation leads is the world's smallest right ventricular defibrillation leads, measuring 6.6 French in size and compatible with 7 French introducers.
  • The small size of the Sprint Fidelis leads enables easier implantation, minimizes venous obstruction, and improves passage into the patient's venous system.
  • ICD leads tend to be heavier and more difficult to implant than pacemaker leads, but the Sprint Fidelis behaves and handles virtually identical to a pacemaker lead.
  • Dr. Raymond Yee, MD, of the London Health Sciences Center, performed the first implant and praised the Sprint Fidelis leads, stating that it makes doing an ICD implant a smoother, less arduous experience.
  • The Sprint Fidelis family comes in four models and will complement the Medtronic Sprint Quattro lead family, which are the industry's most implanted defibrillation leads.
  • Sprint Fidelis leads will be available in both quadripolar and tripolar configurations, with active and passive fixation options.
  • Medtronic has received CE mark in Europe and is nearing market release of the Sprint Fidelis leads.
  • The Sprint Fidelis family is designed to provide lifelong solutions for people with chronic disease.

Statistics:

  • The Sprint Fidelis leads measure 6.6 French in size, making them the world's smallest right ventricular defibrillation leads.
  • The Sprint Fidelis leads are compatible with 7 French introducers, enabling easier implantation.
  • The Sprint Fidelis leads are available in four models, offering flexibility in configurational options.
  • Sprint Fidelis leads will be available in both quadripolar and tripolar configurations, providing multiple options for implantation.
  • The Medtronic Sprint Quattro lead family is the industry's most implanted defibrillation leads.

Sources:

  • (NewsRx.com & NewsRx.net) - Original article announcing FDA approval of Sprint Fidelis defibrillation leads.
  • Medtronic, Inc. - Press release announcing FDA approval and market release of Sprint Fidelis leads.